SEC Form 4 · accession 0000899243-15-008211
Marker Therapeutics, Inc. · MRKR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Reddish
Director
Period of report
Nov 12, 2015
Accepted (ET)
Nov 16, 2015 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001094038
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $0.605 | Nov 12, 2015 | A | 150,000 | A | Nov 12, 2015 | Nov 12, 2025 | Common Stock | 150,000 | 154,500 | D |
Explanation of responses
- F1Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan in connection with service as a director of the Company. These shares vest immediately. The option exercise price is the closing price on the date of the grant, November 12, 2015.